Dali University School of Clinical Medicine, Yunnan, China.
Department of Cardiology, The First Affiliated Hospital of Dali University, Yunnan, China.
Medicine (Baltimore). 2024 Nov 1;103(44):e40354. doi: 10.1097/MD.0000000000040354.
Chronic coronary syndrome (CCS) is a major cause of progression to acute coronary syndrome. Due to its insidious onset and complex etiology, this condition is often underestimated and insufficiently recognized, and traditional interventions for risk factors do not effectively control the disease progression. Current research suggests that immune and inflammatory pathways contribute to atherosclerosis and its clinical complications, thereby triggering the progression of CCS to acute coronary syndrome. This article primarily reviews the possible mechanisms of immune and inflammatory responses in CCS, with the aim of providing references for the diagnosis, treatment, and prevention of CCS.
慢性冠状动脉综合征(CCS)是进展为急性冠状动脉综合征的主要原因。由于其隐匿发病和复杂的病因,这种情况经常被低估和识别不足,并且针对危险因素的传统干预措施不能有效控制疾病进展。目前的研究表明,免疫和炎症途径有助于动脉粥样硬化及其临床并发症,从而引发 CCS 向急性冠状动脉综合征的进展。本文主要综述了 CCS 中免疫和炎症反应的可能机制,旨在为 CCS 的诊断、治疗和预防提供参考。